Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly NYSE:LLY |
1.008,93 Mrd. | 23,47 % | 6/6 | 38,18 % | 3,56 % | 10,57 % | UP |
|
Johnson & Johnson NYSE:JNJ |
549,26 Mrd. | 5,26 % | 5/5 | 7,04 % | -25,87 % | 13,95 % | UP |
|
Merck NYSE:MRK |
297,02 Mrd. | 7,71 % | 6/6 | -21,58 % | -15,73 % | 12,26 % | UP |
|
Pfizer NYSE:PFE |
148,41 Mrd. | 7,82 % | 3/6 | -4,89 % | 24,13 % | 7,53 % | UP |
|
Bristol-Myers Squibb NYSE:BMY |
115,58 Mrd. | 1,77 % | 5/6 | 0,08 % | 1,65 % | 14,84 % | UP |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
112,12 Mrd. | 13,44 % | 5/6 | 6,55 % | -2,37 % | 25,64 % | UP |
|
Regeneron Pharmaceuticals NasdaqGS:REGN |
63,97 Mrd. | 9,26 % | 5/6 | 7,53 % | 20,57 % | 35,59 % | DOWN |
|
Zoetis NYSE:ZTS |
33,34 Mrd. | 10,27 % | 6/6 | 6,74 % | 64,77 % | 63,48 % | DOWN |
|
United Therapeutics NasdaqGS:UTHR |
23,25 Mrd. | 15,46 % | 5/6 | 2,37 % | -37,45 % | 25,07 % | UP |
|
Viatris NasdaqGS:VTRS |
18,52 Mrd. | -3,61 % | 5/6 | 3,43 % | -59,91 % | 13,21 % | UP |
|
Catalent NYSE:CTLT |
11,52 Mrd. | -5,82 % | 2/6 | 27,69 % | -22,42 % | 0,03 % | UP |
|
Madrigal Pharmaceuticals NasdaqGS:MDGL |
11,36 Mrd. | 0,00 % | 1/4 | 0,00 % | 0,00 % | 31,18 % | UP |
|
Cytokinetics NasdaqGS:CYTK |
9,82 Mrd. | -1,86 % | 1/6 | 9,11 % | -52,14 % | 43,86 % | UP |
|
Corcept Therapeutics NasdaqCM:CORT |
8,04 Mrd. | 7,35 % | 3/6 | 131,43 % | -28,11 % | 0,15 % | UP |
|
TG Therapeutics NasdaqCM:TGTX |
5,75 Mrd. | 63,06 % | 3/5 | 42,79 % | 92,38 % | 23,27 % | UP |
|
Ligand Pharmaceuticals NasdaqGM:LGND |
4,73 Mrd. | 7,75 % | 5/6 | 10,78 % | -68,93 % | 15,51 % | UP |
|
Indivior Pharmaceuticals NasdaqGS:INDV |
3,22 Mrd. | 30,35 % | 5/6 | 12,29 % | 10,11 % | 41,56 % | DOWN |
|
Soleno Therapeutics NasdaqGM:SLNO |
2,76 Mrd. | 0,00 % | 3/4 | 0,00 % | 0,00 % | -0,02 % | UP |
|
Supernus Pharmaceuticals NasdaqGM:SUPN |
2,59 Mrd. | 2,25 % | 3/6 | 7,50 % | -10,34 % | 43,18 % | DOWN |
|
Endo OTCPK:NDOI |
1,80 Mrd. | 3,65 % | 0/5 | 61,08 % | 23,81 % | -100,00 % | DOWN |



























